HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma

Anti-angiogenesis has emerged as a standard of care for metastatic renal cell carcinoma. However, long-lasting efficacy is seldom reached, and evasive resistance eventually occurs under anti-angiogenic tyrosine kinase inhibitor (TKI) therapy. To establish new therapeutic strategies, investigating th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Xiang-Me, Liu, Shu-Yu, Tsai, Yi-Ta, Sun, Guang-Huan, Chang, Sun-Yran, Huang, Shih-Ming, Cha, Tai-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564801/
https://www.ncbi.nlm.nih.gov/pubmed/28572533
http://dx.doi.org/10.18632/oncotarget.17923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564801/
https://www.ncbi.nlm.nih.gov/pubmed/28572533
http://dx.doi.org/10.18632/oncotarget.17923

Ejemplares similares